10x Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	473.97	344.07	359.28	219.75	587.45
Short-Term Investments	49.44	49.34	29.41	210.24	-
Cash & Short-Term Investments	523.41	393.4	388.7	429.98	587.45
Cash Growth	33.05%	1.21%	-9.60%	-26.80%	-11.48%
Accounts Receivable	47.01	87.86	114.83	104.21	85.25
Other Receivables	35.48	0.61	-	-	-
Receivables	82.49	88.47	114.83	104.21	85.25
Inventory	56.34	83.11	73.71	81.63	59.97
Prepaid Expenses	22.21	19.41	18.79	16.58	13.9
Restricted Cash	-	-	-	2.63	1.03
Total Current Assets	684.45	584.39	596.02	635.04	747.59
Property, Plant & Equipment	287.16	309.94	344.93	359.21	230.41
Goodwill	4.51	4.51	4.51	4.51	4.51
Other Intangible Assets	62.33	15.67	16.62	22.86	25.4
Other Long-Term Assets	2.91	4.13	3.06	7.37	10.92
Total Assets	1,041	918.64	965.14	1,029	1,019
Accounts Payable	12.73	12.91	15.74	21.6	17.35
Accrued Expenses	51.89	52.07	45.98	51.9	53.27
Current Portion of Leases	10.99	9.29	11.52	9.04	5.13
Current Income Taxes Payable	7.22	4.94	5.05	4.08	4.62
Current Unearned Revenue	23.9	20.66	13.15	7.87	5.34
Other Current Liabilities	46.73	17.77	35.73	36.48	24.64
Total Current Liabilities	153.45	117.63	127.16	130.96	110.36
Long-Term Leases	73.38	73.33	83.85	86.14	76.85
Long-Term Unearned Revenue	10.5	12.51	8.81	3.17	-
Other Long-Term Liabilities	7.71	5.03	4.28	2.98	14.05
Total Liabilities	245.04	208.5	224.1	223.24	201.26
Common Stock	0	0	0	0	0
Additional Paid-In Capital	2,307	2,178	2,026	1,839	1,681
Retained Earnings	-1,511	-1,467	-1,284	-1,029	-863.32
Comprehensive Income & Other	0.23	-0.49	-0.43	-4.34	0.02
Total Common Equity	796.33	710.13	741.04	805.74	817.57
Shareholders' Equity	796.33	710.13	741.04	805.74	817.57
Total Liabilities & Equity	1,041	918.64	965.14	1,029	1,019
Total Debt	84.36	82.61	95.37	95.18	81.98
Net Cash (Debt)	439.05	310.79	293.33	334.81	505.47
Net Cash Growth	41.27%	5.95%	-12.39%	-33.76%	-15.84%
Net Cash Per Share	3.52	2.58	2.50	2.94	4.58
Filing Date Shares Outstanding	127.75	122.3	119.17	115.36	112.84
Total Common Shares Outstanding	127.69	122.29	119.1	115.2	112.51
Working Capital	531	466.75	468.86	504.08	637.23
Book Value Per Share	6.24	5.81	6.22	6.99	7.27
Tangible Book Value	729.49	689.95	719.92	778.37	787.66
Tangible Book Value Per Share	5.71	5.64	6.04	6.76	7.00
Land	36.77	36.77	36.77	36.78	36.1
Buildings	147.49	147.09	146.04	-	-
Machinery	103.26	97.04	96.6	76.87	62.69
Construction In Progress	2.93	5.15	7.25	153	52.19
Leasehold Improvements	89.72	89.57	96.41	91.52	67.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.